Sanctuary Advisors LLC Invests $5.53 Million in Ventas, Inc. $VTR

Sanctuary Advisors LLC acquired a new position in shares of Ventas, Inc. (NYSE:VTR) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 62,228 shares of the real estate investment trust’s stock, valued at approximately $5,526,000.

Other large investors have also modified their holdings of the company. Dynamic Wealth Strategies LLC acquired a new position in Ventas in the first quarter valued at $25,000. Silvant Capital Management LLC purchased a new position in shares of Ventas during the second quarter worth about $28,000. Meeder Asset Management Inc. acquired a new stake in shares of Ventas during the second quarter worth about $30,000. Wiser Advisor Group LLC acquired a new stake in shares of Ventas during the third quarter worth about $27,000. Finally, IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas in the 4th quarter valued at about $30,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Stock Performance

NYSE VTR opened at $93.47 on Tuesday. Ventas, Inc. has a 1-year low of $66.38 and a 1-year high of $101.60. The company has a market capitalization of $47.94 billion, a P/E ratio of 173.09, a PEG ratio of 2.15 and a beta of 0.69. The business has a 50 day moving average price of $91.56 and a 200 day moving average price of $87.26. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the firm posted $0.87 EPS. The company’s quarterly revenue was up 21.7% compared to the same quarter last year. Sell-side analysts expect that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Insider Buying and Selling

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. UBS Group raised their price target on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research note on Monday, May 4th. KeyCorp raised their target price on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Jefferies Financial Group lifted their target price on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Royal Bank Of Canada upped their price target on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Finally, JPMorgan Chase & Co. increased their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $98.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.